Influenza virus infection in hospitals is a very important clinical issue. The objective of this study was to describe the effect of oseltamivir in controlling a nosocomial influenza virus infection with an observational study and case report.
Introduction
Influenza can be transmitted between patients and medical staff members (nurses and doctors) in hospital settings and result in increased morbidity and mortality, especially in immunocompromised inpatients. 1, 2 In addition, since outbreaks of influenza might result in the functional deterioration of both acute hospital settings and healthcare facilities for care of chronic diseases, it is important to take prompt action to prevent droplet transmission of the influenza virus after the index cases are identified. Of course, in the hospital setting, all staff members should receive vaccination for influenza. In addition, if the number of patients with influenza increases in the community, staff members should wear surgical masks to prevent droplet infection. However, even though the staff have been vaccinated against influenza virus, it is impossible to prevent all nosocomial influenza virus infections. In addition, hospitalized patients are not necessarily vaccinated, and often have impaired immune systems. Chemoprophylaxis for those who have had close contact with index cases may supplement pre-requisite vaccination to control influenza virus infection. 3 Although there are many reports concerning the efficacy of chemoprophylaxis to prevent influenza outbreaks, the usefulness of chemoprophylaxis has not been fully established. More specifically, the effectiveness of chemoprophylaxis in the hospital setting [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] has not been well established. This study reports an episode of influenza virus infection among staff members and inpatients at a university hospital during a period of epidemic influenza in the community. In addition, the usefulness of the prophylactic administration of oseltamivir to prevent nosocomial influenza viral infection will be discussed.
Patients and Methods Epidemiological survey
The average number of influenza patients per hospital per week was evaluated. Then, a plot of influenza patients from January 2009 to March 2011 in Okinawa was made.
During the same period, we counted those (staff members, inpatients, and patients' family members) with an influenza virus infection observed in the University of the Ryukyus Hospital (a specialized university hospital with 600 beds) during 2009-2011.
Identification of cases with influenza virus infection
According to these epidemics observed in community, influenza virus infections were observed in several wards in the University of the Ryukyus Hospital (600 beds). For the purpose of the epidemiological investigation, a case is defined as any person who had an acute respiratory illness with two or more of the following symptoms; cough, sore throat, myalgia, and fever (>37.0°C). A survey was conducted, recording demographic data (name, sex, age, and profession), date of first symptoms, current therapy, and major symptoms (fever, cough, sore throat, myalgia, and headache). Index cases of influenza were identified by selfreporting. Influenza was diagnosed by clinical examination and an immunochromatographic test for influenza virus A and B antigens (Tauns Laboratories, Inc., Shizuoka, Japan). Patients who had influenza-like symptoms (fever, arthralgia, and upper respiratory symptoms) during influenza outbreaks, and tested positive for influenza antigen, were diagnosed with influenza. Examples of close contact with the index cases included the following: i) physical care, ii) verbal communication without personal protective equipment, and iii) sharing a room. Individuals who were considered to have close contact with the index cases were actively monitored for symptoms for 10 days after identification. A nasopharyngeal swab was obtained from all patients and immediately examined by rapid diagnostic kits for influenza. The diagnosis of influenza was performed based on clinical symptoms and a definitive diagnosis of influenza was made based on the results of repeated rapid diagnostic kits.
Influenza chemoprophylaxis
Chemoprophylaxis was recommended for hospitalized patients who were considered to have had close contact with index cases in the ward to minimize an outbreak with a hospital burden.
Journal of General and Family Medicine 2015, vol. 16, no. 3 Among several neuraminidase inhibitors (NIs); oseltamivir was used for influenza chemoprophylaxis. Written informed consent was obtained for the administration of these drugs. Adults with full renal function received 75 mg/day of oseltamivir for 7 days. Patients on hemodialysis received a single dose of 75 mg of oseltamivir.
Data concerning staff influenza vaccinations were obtained from the employee health service records.
Control measures
Symptomatic staff members with a definite influenza infection were sent home for one week. Inpatients with influenza infection were isolated under respiratory infection precautions (single room, gloves, mask), and the number of staff members and visitors entering the rooms of patients with influenza was minimized.
Staff members and patients with a definite influenza infection were treated by anti-influenza drugs with a standard dosage. In outbreaks, oseltamivir (75 mg orally, once a day, for 7 days) was administered to asymptomatic staff members and inpatients who had contact with infected patients.
Review of the literature
We reviewed articles concerning prophylactic use of oseltamivir through the MEDLINE (keywords were influenza and prophylaxis). Articles not listed in the MEDLINE and those written in languages other than English were excluded. 
Results

Epidemiology of influenza in the community
Number of cases those diagnosed in the University of the Ryukyus Hospital
In the hospital setting, we experienced many cases of influenza virus infection ( Figure 2 ). As compared with In January 2011, we experienced outbreak of influenza virus infection (caused by the pandemic H1N1 2009 virus) in the west 10 th ward (the ward of dermatology and the urology department). On January 29 th , 2011, one staff member complained of a respiratory illness that met the case definition. On January 30 th , another staff member and seven inpatients (A, B, C, D, E, F, and G in Figure 3 ) in the west 10 th ward complained of a respiratory illness that met the case definition and were diagnosed as having influenza using the rapid diagnostic kit. On January 31 st , one staff member and three inpatients (H, I, and J in Figure 3 ) complained of a respiratory illness that met the case definition and were diagnosed as having influenza using the rapid diagnostic kit.
On February 1 st , 2011, to prevent nosocomial influenza As shown in Figure 1 , three influenza epidemics recently occurred in Okinawa, Japan. During these three epidemics, if the number of patients increased in Okinawa prefecture, the number of patients diagnosed in our university hospital (staff members, inpatients, or patients' family members) also increased. Horizontal bar demonstrates number of patients with influenza confirmed by the rapid diagnostic test. Figure 4 ) We evaluated sequential temperatures of inpatients before and after being diagnosing as having influenza infection. However, mean increase of body temperature was slight. As shown in Figure 4 , mean highest temperature was 37.7 « 0.82°C (mean « standard er-ror). Therefore, it was very difficult to diagnose influenza infection based on a higher body temperature without the rapid diagnostic kit. In addition, since clinical symptoms for medical staff members were more trivial than patients, it was very difficult to diagnose as influenza without the rapid diagnostic kit (data not shown). Since nosocomial infection was strongly suspected, we evaluated temperatures of inpatients diagnosed to have influenza infection. As shown in this figure, highest temperature was 37.7 « 0.82°C (mean « standard error) at one day after the diagnosis of influenza. (Table 1) There are many reports regarding influenza prophylaxis. Although, there are few reports concerning prophylaxis of nosocomial infection before the out-break of pandemic A H1N1, 10, 16 there are many articles concerning the prophylactic use of NIs in nosocomial settings after the outbreak of pandemic A H1N1 ( Table 1) . [4] [5] [6] [7] [8] [9] [11] [12] [13] [14] 
Discussion
This report emphasizes the usefulness of anti-influenza drugs (oseltamivir) in preventing a nosocomial outbreak of influenza during a period of epidemic influenza.
In Japan, among four NIs, oseltamivir, zanamivir, and laninamivir are approved to use for both treatment and prophylaxis of influenza. Early administration of NIs reduces the duration and severity of symptoms as well as the overall risk of complications. [17] [18] [19] In hospital settings, several observational studies have reported that post-exposure NIs prophylaxis is effective in controlling outbreaks. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Although most of them are observational studies, a double-blind randomized control trial found that long-term use of oseltamivir for influenza prophylaxis was effective for transplant patients to reduce the incidence of influenza. 4 On the other hand, in school settings, it has been pointed out that extensive use of chemoprophylaxis may be impractical and costly. [20] [21] [22] Although the NIs are being introduced in clinical practice and will probably be useful in controlling outbreaks more easily, 18, 29 amazingly, there were few reports which evaluated the efficacy of prophylactic use of anti-neuraminidase inhibitors in hospitals before the prevalence of pandemic 2009 A (H1N1). 10, 16 Higa et al. retrospectively evaluated the use of neuraminidase inhibitor chemoprophylaxis for prevention of nosocomial spread of influenza in a university hospital. 10 They have demonstrated that when both the index cases and the close contacts were hospitalized patients, the incidence of influenza was significantly lower among the close contacts who received chemoprophylaxis than among those who did not. Fujita et al. have reported the usefulness of osertamivir prophylaxis (five days duration) in a nosocomial outbreak in a gynecology/obstetrics department. 16 In addition, Lee et al. evaluated the efficacy of ring chemoprophylaxis (geographically targeted containment by means of prophylaxis) with oseltamivir to control outbreaks of the 2009 H1N1 influenza in semiclosed environ-ments. 12, 13 In hospital and nursing home settings, health care workers (HCW) have been occasionally been identified as index cases in outbreaks. 23, 24 Up to 23% of HCW might present clinical or subclinical influenza infections at the time of epidemics. 25 It has been reported that the influenza vaccine is effective in preventing influenza infection in HCW and may reduce the number of days absent. 26 In addition, it has been demonstrated that the attack rate of influenza outbreaks in nursing homes and chronic care facilities depends to some extent on the vaccination status of residents and staff members. 27, 28 However, in our university hospital, since all staff members including the first staff member infected had received a vaccination for influenza virus in November 2010, prevention of nosocomial influenza virus infection seems to be impossible by vaccination alone.
In our experience, clinical symptoms of influenza virus infection were trivial especially in staff members as reported previously. 30 In this literature, the median temperature was 36.7°C for those testing positive for H1N1 and 36.3°C for those testing negative. 30 Of those testing positive for H1N1, 58/85 (68%) were afebrile (temperature,¯37°C). 30 Therefore, epidemiological and microbiological diagnosis using a rapid diagnostic test and the quick institution of infection control measures prevented the influenza virus infection's spread to most of the inpatients.
Our experiences have suggested the usefulness of oseltamivir in preventing nosocomial influenza virus infection. With a review of the literature, we consider that prophylaxis with anti-influenza drugs should be highly recommended in hospital settings.
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